Prot# A4091025: A Phase 3, Multi-Center, Randomized, Double-Blind, Controlled Study of the Long-Term Analgesic Efficacy and Safety of Tanezumab Alone or in Combination with Non-Steroidal Anti-Inflammatory Drugs (Nsaids) versus Nsaids Alone in Patients wi

Project: Research project

Project Details

StatusFinished
Effective start/end date5/6/095/6/12

Funding

  • INC Research, LLC (A4091025)
  • Pfizer Inc. (A4091025)